Related Funds
Fund Name | Location |
Arca Continental | Mexico, Nuevo León, Nuevo Leon |
Asset One | Seoul, Seoul-t'ukpyolsi, South Korea |
BankDhofar | Muscat, Muscat, Oman |
Cambridge University Press | - |
Chongda Touzi | China, Shanghai |
FINCA Ventures | - |
HuoMao TV | China, Shanghai |
Meyer Bergman | England, London, United Kingdom |
Orefa Investment | - |
OTB Ventures | Amsterdam, Noord-Holland, The Netherlands |
Palisades Technology Partners | Englewood Cliffs, New Jersey, United States |
PICC Health Insurance | Beijing, Beijing Shi, China |
Plymouth Growth Partners | Ann Arbor, Michigan, United States |
Provident Capital | Gurgaon, Haryana, India |
Puchao Capital | China, Shanghai |
Qianxi Taihe Chuangtou | China, Jiangsu, Nanjing |
Roc Partners | Australia, New South Wales, Sydney |
T V Sundram Iyengar & Sons Limited | Chennai, India, Tamil Nadu |
Xinjiang Kangpu Jianshe Touzi | China, Shanxi, Xinjiang |
Zhejiang LAND Venture Capital Investment | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Orchard Therapeutics | $110M | 20 Dec 2017 | London, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Orchard Therapeutics | $110M | 20 Dec 2017 | London, England, United Kingdom |